These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20233088)

  • 1. Prostaglandins in pathogenesis and treatment of multiple sclerosis.
    Mirshafiey A; Jadidi-Niaragh F
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):543-54. PubMed ID: 20233088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Neuropharmacology; 2010 Sep; 59(3):180-9. PubMed ID: 20493888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.
    Hata AN; Breyer RM
    Pharmacol Ther; 2004 Aug; 103(2):147-66. PubMed ID: 15369681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages and neurodegeneration.
    Hendriks JJ; Teunissen CE; de Vries HE; Dijkstra CD
    Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
    Brück W
    J Neurol; 2005 Nov; 252 Suppl 5():v3-9. PubMed ID: 16254699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.
    Akassoglou K; Bauer J; Kassiotis G; Pasparakis M; Lassmann H; Kollias G; Probert L
    Am J Pathol; 1998 Sep; 153(3):801-13. PubMed ID: 9736029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
    Szczuciński A; Losy J
    Acta Neurol Scand; 2007 Mar; 115(3):137-46. PubMed ID: 17295707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of multiple sclerosis.
    Williams KC; Ulvestad E; Hickey WF
    Clin Neurosci; 1994; 2(3-4):229-45. PubMed ID: 7749893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the chemokine system for multiple sclerosis treatment.
    Glabinsk AR; Ransohoff RM
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1712-9. PubMed ID: 11892933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pathogenic role of inflammation in multiple sclerosis].
    Martino G; Furlan R; Poliani PL
    Rev Neurol; 2000 Jun 16-30; 30(12):1213-7. PubMed ID: 10935253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intercellular adhesion molecules and chemotaxic factors in the pathogenesis of multiple sclerosis].
    González-Amaro R; Sánchez-Madrid F
    Rev Neurol; 2002 Nov 16-30; 35(10):985-93. PubMed ID: 12436404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of multiple sclerosis.
    Agrawal SM; Yong VW
    Int Rev Neurobiol; 2007; 79():99-126. PubMed ID: 17531839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
    Sindic CJ
    Bull Mem Acad R Med Belg; 2002; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Janus faces of microglia in multiple sclerosis.
    Sanders P; De Keyser J
    Brain Res Rev; 2007 Jun; 54(2):274-85. PubMed ID: 17383006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
    Hamann I; Zipp F; Infante-Duarte C
    J Neurol Sci; 2008 Nov; 274(1-2):31-8. PubMed ID: 18706659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia and multiple sclerosis.
    Jack C; Ruffini F; Bar-Or A; Antel JP
    J Neurosci Res; 2005 Aug; 81(3):363-73. PubMed ID: 15948188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis.
    Minagar A; Carpenter A; Alexander JS
    Int Rev Neurobiol; 2007; 79():1-11. PubMed ID: 17531835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Properties of Cytokines in Multiple Sclerosis: Pros and Cons.
    Wang K; Song F; Fernandez-Escobar A; Luo G; Wang JH; Sun Y
    Am J Med Sci; 2018 Dec; 356(6):552-560. PubMed ID: 30447707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.